MENU
SPRY
AS OF
Dec 12 closing price
Price
$10.24
Change
-$0.98 (-8.73%)
Capitalization
1.01B
95 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ARS Pharmaceuticals (SPRY) Ownership - Who owns ARS Pharmaceuticals?

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.01B
P/E Ratio
151.25
Total Cash
288.21M
Projected Growth
N/A
Total Debt
97.76M
Revenue
142.77M
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
2.92
Total Debt/Equity
N/A
Revenue/Share
1.38 USD as % of share price

Fundamentals

SPRY
Capitalization
1.01B
P/E Ratio
151.25
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
288M
Total Cash/Share
2.92
Total Debt
97.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.38%
Revenue
143M
ROE
N/A
Book Value
148M
P/B Ratio
6.85
Cash Flow
N/A
Earnings
-0.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
6.66
Current Revenue Per Employee
194616.77
Dividends Per Share - Security
N/A
EBITDA
-90.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.80
Revenue To Assets
-27.11
Shares Held By Institutions
1.16B
Shares Outstanding - Current
98.8M
Total Liabilities
225M
Total Volume MTD
N/A
Value
-1
Gain YTD
6.351
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SPRY
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRY showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SPRY
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com